Toner K, Bollard CM. EBV+ lymphoproliferative diseases: opportunities for leveraging EBV as a therapeutic target. Blood, J American Soc Hematol. 2022;139(7):983–94.

CAS  Google Scholar 

Damania B, Kenney SC, Raab-Traub N. Epstein-Barr virus: Biology and clinical disease. Cell. 2022;185(20):3652–70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lv K, Yin T, Yu M, Chen Z, Zhou Y, Li F. Treatment Advances in EBV Related Lymphoproliferative Diseases. Front Oncol. 2022;12: 838817.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Crombie JL, LaCasce AS. Epstein Barr virus associated B-cell lymphomas and iatrogenic lymphoproliferative disorders. Front Oncol. 2019;9:109.

Article  PubMed  PubMed Central  Google Scholar 

Kim WY, Montes-Mojarro IA, Fend F, Quintanilla-Martinez L. Epstein-Barr virus-associated T and NK-cell lymphoproliferative diseases. Front Pediatr. 2019;7:71.

Article  PubMed  PubMed Central  Google Scholar 

Shafiee A, Shamsi S, Gargari OK, Beiky M, Allahkarami MM, Miyanaji AB, et al. EBV associated T- and NK-cell lymphoproliferative diseases: A comprehensive overview of clinical manifestations and novel therapeutic insights. Rev Med Virol. 2022;32(4):e2328.

Article  CAS  PubMed  Google Scholar 

Lima M. Aggressive mature natural killer cell neoplasms: from epidemiology todiagnosis. Orphanet J Rare Dis. 2013;8:1–10.

Article  Google Scholar 

Phan A, Veldman R, Lechowicz MJ. T-cell lymphoma epidemiology: the known and unknown. Curr Hematol Malig Rep. 2016;11(6):492–503.

Article  PubMed  Google Scholar 

Ni X, Li Z, Li X, Zhang X, Bai G, Liu Y, et al. Socioeconomic inequalities in cancer incidence and access to health services among children and adolescents in China: a cross-sectional study. The Lancet. 2022;400(10357):1020–32.

Article  Google Scholar 

Escalante GM, Mutsvunguma LZ, Muniraju M, Rodriguez E, Ogembo JG. Four Decades of Prophylactic EBV Vaccine Research: A Systematic Review and Historical Perspective. Front Immunol. 2022;13: 867918.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Quintanilla-Martinez L, Swerdlow SH, Tousseyn T, Barrionuevo C, Nakamura S, Jaffe ES. New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders. Virchows Arch. 2023;482(1):227–44.

Article  CAS  PubMed  Google Scholar 

Health Commission Of The People's Republic Of China. National guidelines for diagnosis and treatment of malignant lymphoma 2022 in China. Chin J Cancer Res. 2022;34(5):425–46.

Chinese Society of Hematology CMA, China Hematology Association, Chinese Medical Doctor Association. Chinese consensus on the diagnosis and management of Epstein-Barr virus-related post-transplant lymphoproliferative disorders after hematopoietic stem cell transplantation (2022). Zhonghua Xue Ye Xue Za Zhi. 2022;43(9):10.

Google Scholar 

Rezk SA, Zhao X, Weiss LM. Epstein-Barr virus (EBV)-associated lymphoid proliferations, a 2018 update. Hum Pathol. 2018;79:18–41.

Article  CAS  PubMed  Google Scholar 

Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood, The Journal of the American Society of Hematology. 2016;127(20):2375–90.

CAS  Google Scholar 

Shafiee A, Shamsi S, Kohandel Gargari O, Beiky M, Allahkarami MM, Miyanaji AB, et al. EBV associated T-and NK-cell lymphoproliferative diseases: A comprehensive overview of clinical manifestations and novel therapeutic insights. Rev Med Virol. 2022;32(4): e2328.

Article  CAS  PubMed  Google Scholar 

Chen Z, Wang M, Guan P, Zhao S, Zhang W, Gao L, et al. Comparison of Systemic EBV-positive T-Cell and NK-Cell Lymphoproliferative Diseases of Childhood Based on Classification Evolution: New Classification, Old Problems. Am J Surg Pathol. 2020;44(8):1061–72.

Article  PubMed  Google Scholar 

Xu JX, Hoshida Y, Yang WI, Inohara H, Kubo T, Kim GE, et al. Life-style and environmental factors in the development of nasal NK/T-cell lymphoma: A case–control study in East Asia. Int J Cancer. 2007;120(2):406–10.

Article  CAS  PubMed  Google Scholar 

Chiu BCH, Weisenburger DD. An update of the epidemiology of non-Hodgkin’s lymphoma. Clin Lymphoma. 2003;4(3):161–8.

Article  PubMed  Google Scholar 

Jia J, Song Y, Lin N, Liu W, Ping L, Zheng W, et al. Clinical features and survival of extranodal natural killer/T cell lymphoma with and without hemophagocytic syndrome. Ann Hematol. 2016;95(12):2023–31.

Article  CAS  PubMed  Google Scholar 

Allen CE, McClain KL. Pathophysiology and epidemiology of hemophagocytic lymphohistiocytosis. Hematology Am Soc Hematol Educ Program. 2015;2015(1):177–82.

Article  PubMed  Google Scholar 

Al-Samkari H, Berliner N. Hemophagocytic lymphohistiocytosis. Annu Rev Pathol. 2018;13:27–49.

Article  CAS  PubMed  Google Scholar 

Nourse J, Jones K, Gandhi M. Epstein-Barr virus-related post-transplant lymphoproliferative disorders: pathogenetic insights for targeted therapy. Am J Transplant. 2011;11(5):888–95.

Article  CAS  PubMed  Google Scholar 

Orland M, Sheu M, Patel M, Adcock B, Ardila V, Shrivastava G, et al. Infectious Complications and Mortality in Post-Transplant Lymphoproliferative Disorder Following Solid Organ Transplantation: Experiences of 10 Years in a Single Center. Blood. 2023;142:4404.

Article  Google Scholar 

Lv Y, Zeng Y, Tian M, Song F, Zhang X, Liu S. Research on Coding of Chronic Active Epstein-Barr Virus Infection. Chinese Medical Record. 2023;24(05):24–6.

Google Scholar 

Kimura H, Fujiwara S. Overview of EBV-Associated T/NK-Cell Lymphoproliferative Diseases. Front Pediatr. 2018;6:417.

Article  PubMed  Google Scholar 

Hong M, Ko YH, Yoo KH, Koo HH, Kim SJ, Kim WS, et al. EBV-positive T/NK-cell lymphoproliferative disease of childhood. Korean Journal of Pathology. 2013;47(2):137.

Article  PubMed  PubMed Central  Google Scholar 

van Doesum JA, Niezink AG, Huls GA, Beijert M, Diepstra A, van Meerten T. Extranodal natural killer/T-cell lymphoma, nasal type: diagnosis and treatment. Hemasphere. 2021;5(2):e523.

Article  PubMed  PubMed Central  Google Scholar 

Wang H. Fu B-b, Gale RP, Liang Y. NK-/T-cell lymphomas. Leukemia. 2021;35(9):2460–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tse E, Kwong Y-L. The diagnosis and management of NK/T-cell lymphomas. J Hematol Oncol. 2017;10(1):1–13.

Article  Google Scholar 

van Doesum J, Nijland M, Brink M, Huls G, van Meerten T. A West-European cohort of patients with NK/T-cell lymphoma, a population-based analysis. HemaSphere. 2020;4(S1):EP1238.

Google Scholar 

Karkera AC, Parsons BM, Borgert A, Go RS. NK/T cell lymphoma in the US: A population based study using the National Cancer Database from 1998–2012. Am Soc Clin Oncol. 2016;34(15):e19038.

Tse E, Kwong Y-L. How I treat NK/T-cell lymphomas. Blood, The Journal of the American Society of Hematology. 2013;121(25):4997–5005.

CAS  Google Scholar 

Kwong YL, Khong PL. Central palatal perforation in nasal natural killer cell lymphoma. Br J Haematol. 2011;152(1):2.

Article  PubMed  Google Scholar 

Alaggio R, Amador C, Anagnostopoulos I, Araujo IB, Berti E, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022;36(7):1720–48.

Article  PubMed  PubMed Central  Google Scholar 

Quintanilla-Martinez L, Ko Y, Kimura H, Jaffe E. EBV-positive T-cell and NK-cell lymphoproliferative diseases of childhood. WHO classification of tumours of haematopoietic and lymphoid tissues. 2017:355–62.

Montes-Mojarro IA, Kim WY, Fend F, Quintanilla-Martinez L. Epstein - Barr virus positive T and NK-cell lymphoproliferations: Morphological features and differential diagnosis. Semin Diagn Pathol. 2020;37(1):32–46.

Article  PubMed  Google Scholar